Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
4
×
detroit top stories
eli lilly
4
×
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
amgen
clinical trials
ipo
bristol-myers squibb
cancer
deals
genentech
generic drugs
glaxosmithkline
lasmiditan
What
drugs
4
×
bio
roundup
fda
new
pharmaceutical
won
appetite
approval
arguments
august
bails
big
biotech
black
brand
bread
bridgebio
busy
butter
buyout
cancer
capital
car
cash
class
commercialized
companies
competitors
days
decades
decisions
develop
devices
diabetes
diamond’s
drug
eli
emerges
firm
Language
unset
Current search:
xconomy.com
×
drugs
×
" detroit blog main "
×
" eli lilly "
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More